Member Info for bakky

a couple of empty chairs will do as good a job as Hall/Salazar it seems! I suppose we can't point too many fingers until we get the outcome. I just hope that it's a max of the $1m if anything at all. If it's anything more than that, then another feck up by someone putting it in the rns.

this is my preferred route failing a 10p offer;
'move team on and replace (we have a COO and CFO who could step into roles overnight) and back to selling domains in preparation for sale in 12/18 months'.

taking it private is what I have thought for quite a while now. Who would take 6p? 10p will suffice, but that won't happen. So around 8p will do me.

wonder when this comes online? •High throughput options available (automated version to follow). Anyone know how much it speeds up the process?

in which direction?

I'll second that YHAL. Let's just hope they don't have to refund a bigger sum!

no probs Nat, non taken!

well if we work on Align metrics then this will be around 45p when the 20k tests come online? Should be around 32p right now with 10k going through, according to them! hmmm!

Natdan, not my expectations, just the words of Mr Sales genomic director. I believe it will happen though!

Bakky,
'limited' capacity for testing stretches to 'tens of thousands per month', which isn't too shabby as an add on rev stream to be fair!“
Your expectations, just seven days ago.

not quite sure if or how they can be intentionally cooking the books tbh. I would expect that it's more to do with incompetence/negligence than anything criminal/fraudulent, but then again!!??

'and there is potential for further expansion in line with anticipated demand'...….. that'll do me for starters!

'Capacity is being further expanded to 20,000 tests per month which is due to come on stream in the third quarter. This will increase COVID-19 testing revenue potential to approximately £1m per month and there is potential for further expansion in line with anticipated demand. This in-house testing uses Yourgene's own Clarigene® Sars-CoV-2 product, which is also being sold internationally through our distribution network in our channel markets and through our growing direct sales force. Regulatory submissions for Clarigene® are underway to access additional key regions and enable further geographical penetration'.

lol!! true indeed!!

bottom line is this is still a profitable business we think/hope. It's not going bust is it? Hopefully hear this week. It wouldn't bother me one jot if the two head honchos were offloaded either!

Twix, even.

I thought Tix said he had 'retired' from this bb and wouldn't post again? hmmm!

'It doesn't look like the news of' a vaccine has impaired NCYT's share price it has to be said'
lol have you looked at their sp today? Something has spooked it!

if a vaccine is imminent and Covid soon becomes a thing of the past which companies have got the most to lose? Most of those Covid stocks have not got a lot to fall back on. Just look where they were 9/ 12 months ago pre covid. I would be more worried if I held those stocks because a vaccine will hit them hardest . If Ygen are deemed to have missed the boat then what about some of the others who haven't even got a product anywhere near market yet.

if peoples expectations were not so ridiculous then there wouldn't be a problem!

andymiller; you said, 'Let's be honest not what we were looking for'...just what were you/we looking for??? For me I am happy to hear they are doubling and more Covid testing/sales. Not sure if this includes govt work or not?

regards Covid, they have done what they intended, 10k for Oct,..done. They are doubling/tripling up as we speak. and this still isn't good enough. just shows how far in the clouds peoples heads are. Hilarious!!
Question to the disappointed; what were you expecting??